Atlas Trials

Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)

Clinical trial NCT03597594 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03597594
Sponsor
St. Jude Children's Research Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Severe Combined Immunodeficiency
Start date
2021-09-02
Primary completion
2027-07-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.